Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to ...

Company to Host Conference Call Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m.

Optinose (NASDAQ: OPTN) has announced plans to release its financial results for the fourth quarter and full year of 2024, ...

YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced ...

Members of the Company's leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Thursday, March 20, ...

OptiNose (NASDAQ:OPTN – Get Free Report) is projected to release its earnings data before the market opens on Thursday, March 6th. Analysts expect OptiNose to post earnings of ($0.67 ...

Nasal Polyps Treatment Market Research Report The global nasal polyps treatment market is expected to reach around $4,243.9 million by 2030 ...

Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...

Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced preliminary ...

Turning Point Brands Inc (TPB) is expected to report $0.69 for 4Q. VYNE Therapeutics Inc (VYNE) is expected to report $-0.29 for 4Q. Werewolf Therapeutics Inc (HOWL) is expected to report $-0.43 for ...